Organogenesis Holdings Inc (ORGO) Stock Price, Quote & News

Company Profile

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. Its advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts for use in the care of chronic and acute wounds as protective barriers and extracellular matrix (ECM) scaffolds; Apligraf, a bioengineered bi-layered skin substitute for the treatm...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 781 575 0775

Website: organogenesis.com

Address:

85 Dan Road, Canton, United States

Monticello4 Apr. 24 at 7:27 PM

$ORGO Such great timing, intuition, know-how, and SOPHISTICATION...one just has to ask this simple queston:

0 · Reply

Monticello4 Apr. 24 at 5:50 PM

$ORGO Mobags with yet another fabulous prediction! How does she do it?

0 · Reply

Monticello4 Apr. 24 at 3:47 PM

$ORGO WOW! RARE OPPORTUNITY HERE!!!!

0 · Reply

Monticello4 Apr. 24 at 9:47 AM

$ORGO the Village Idiot strikes again!

0 · Reply

Mobagri Apr. 20 at 6:37 PM

$ORGO mdxg losing market shares with mass layoffs. Good news for ORGO

1 · Reply

Mobagri Apr. 20 at 3:25 PM

$ORGO with the mass layoffs at Mimedyx and other skin substitute scam firms, ORGO can capture a lot of new accounts. They have to add PuraPly to Apligraft and Dermagraft as premier PMA products with higher reimbursement. And then Renu comes in play…..

0 · Reply

Trending__Now Apr. 15 at 3:43 PM

$ORGO recommended at $2.37. Still early in recovery stage. IF you're going to take a position and willing to hold to end of 2027 while they work through CMS policy change, then revenues should recover. Share price may still double this year depending. For the current price risk appears to be in. Over sold. Good luck.

0 · Reply

josegodoy Apr. 14 at 3:22 PM

$ORGO opened a small position today

0 · Reply

Monticello4 Apr. 9 at 8:44 PM

$ORGO ...

0 · Reply

Mobagri Apr. 9 at 4:21 AM

$ORGO what are you doing in this board? Are you that sore about Mimidyx that you troll here? Do you troll Integra, Smith&Nephew, etc? Seems like you have no other investments in any company. You claim you’re not even invested in MDXG, only work for them. Low rank rep or something like that. What a loser.

0 · Reply

What's Going On With Organogenesis Stock On Wednesday?

Apr 7, 2026, 8:22 AM EDT - 18 days ago

Organogenesis Stock Rockets After Diabetic Foot Ulcer Trial Posts Statistically Significant Win

Apr 6, 2026, 7:02 PM EDT - 18 days ago

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM

Apr 6, 2026, 5:30 PM EDT - 18 days ago

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain

Apr 6, 2026, 7:30 AM EDT - 19 days ago

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

Feb 26, 2026, 4:05 PM EST - 2 months ago

Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record Revenue

Feb 19, 2026, 4:05 PM EST - 2 months ago

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026

Dec 23, 2025, 4:05 PM EST - 4 months ago

Organogenesis Announces Initiation of Biologics License Application for ReNu®

Nov 6, 2025, 4:05 PM EST - 6 months ago

Organogenesis Holdings Inc. Reports Third Quarter 2025 Financial Results, Posts Record Revenue and Raises 2025 Guidance

Nov 3, 2025, 1:10 PM EST - 6 months ago

Organogenesis Applauds CMS's Significant Step In Payment Reform

Oct 31, 2025, 4:05 PM EDT - 6 months ago

Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Oct 17, 2025, 2:20 PM EDT - 6 months ago

Organogenesis Holdings Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ORGO

Oct 1, 2025, 4:05 PM EDT - 7 months ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025

Sep 26, 2025, 11:24 AM EDT - 7 months ago

Why Is Organogenesis Stock Trading Lower Friday?

Sep 25, 2025, 4:50 PM EDT - 7 months ago

Organogenesis Provides Update on Second Phase 3 ReNu® Study

Aug 27, 2025, 4:05 PM EDT - 8 months ago

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September

Aug 7, 2025, 4:05 PM EDT - 9 months ago

Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results

Jul 22, 2025, 4:05 PM EDT - 9 months ago

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025

Jul 15, 2025, 9:00 AM EDT - 10 months ago

Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation

May 8, 2025, 4:05 PM EDT - 1 year ago

Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results

Apr 11, 2025, 4:05 PM EDT - 1 year ago

Organogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness

Apr 7, 2025, 4:05 PM EDT - 1 year ago

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Feb 27, 2025, 4:05 PM EST - 1 year ago

Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results

Jan 27, 2025, 7:30 AM EST - 1 year ago

Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025

Nov 22, 2024, 4:05 PM EST - 1 year ago

Organogenesis Expands Manufacturing Capacity to Support Future Growth

Nov 15, 2024, 9:25 AM EST - 1 year ago

Organogenesis Commends Final LCDs

Nov 12, 2024, 4:01 PM EST - 1 year ago

Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock

Nov 11, 2024, 5:05 PM EST - 1 year ago

Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis

Oct 16, 2024, 7:30 AM EDT - 1 year ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024

Oct 1, 2024, 4:05 PM EDT - 1 year ago

Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers

Aug 8, 2024, 4:04 PM EDT - 1 year ago

Organogenesis Shares ReNu® Program Update

Jul 15, 2024, 4:05 PM EDT - 1 year ago

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

Jun 6, 2024, 4:05 PM EDT - 2 years ago

Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference

May 2, 2024, 7:00 AM EDT - 2 years ago

Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis

Apr 16, 2024, 7:30 AM EDT - 2 years ago

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

Feb 29, 2024, 4:05 PM EST - 2 years ago

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance

Feb 12, 2024, 7:30 AM EST - 2 years ago

Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Feb 8, 2024, 4:05 PM EST - 2 years ago

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024

Nov 9, 2023, 4:05 PM EST - 2 years ago

Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results

Oct 5, 2023, 7:30 AM EDT - 2 years ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023

Sep 28, 2023, 9:15 AM EDT - 2 years ago

Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS

Sep 6, 2023, 4:05 PM EDT - 2 years ago

Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Aug 9, 2023, 4:05 PM EDT - 2 years ago

Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 Guidance

Jul 10, 2023, 7:30 AM EDT - 3 years ago

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023

May 21, 2023, 8:20 AM EDT - 3 years ago

TipRanks reveals the top 10 health care sector analysts of the past decade

CABA CYH EXAS MRNA NVAX PFE RARE

May 10, 2023, 4:05 PM EDT - 3 years ago

Organogenesis Holdings Inc. Reports First Quarter 2023 Financial Results

Monticello4 Apr. 24 at 7:27 PM

$ORGO Such great timing, intuition, know-how, and SOPHISTICATION...one just has to ask this simple queston:

0 · Reply

Monticello4 Apr. 24 at 5:50 PM

$ORGO Mobags with yet another fabulous prediction! How does she do it?

0 · Reply

Monticello4 Apr. 24 at 3:47 PM

$ORGO WOW! RARE OPPORTUNITY HERE!!!!

0 · Reply

Monticello4 Apr. 24 at 9:47 AM

$ORGO the Village Idiot strikes again!

0 · Reply

Mobagri Apr. 20 at 6:37 PM

$ORGO mdxg losing market shares with mass layoffs. Good news for ORGO

1 · Reply

Mobagri Apr. 20 at 3:25 PM

0 · Reply

Trending__Now Apr. 15 at 3:43 PM

0 · Reply

josegodoy Apr. 14 at 3:22 PM

$ORGO opened a small position today

0 · Reply

Monticello4 Apr. 9 at 8:44 PM

$ORGO ...

0 · Reply

Mobagri Apr. 9 at 4:21 AM

0 · Reply

Monticello4 Apr. 8 at 11:38 PM

$ORGO ...

0 · Reply

Mobagri Apr. 8 at 8:45 PM

$ORGO https://stocks.apple.com/Awxv-ArqkSIa2CrxTX_Y2Dg

0 · Reply

Mobagri Apr. 8 at 8:41 PM

$ORGO this mdxg troll blocked me when ORGO went up two days ago. Now that it dropped he unblocked me and posts cartoons. What a timid coward.

0 · Reply

Mobagri Apr. 8 at 8:17 PM

$ORGO. Go worry about MDXG and your employment. You blocked me for two days coward.

0 · Reply

Monticello4 Apr. 8 at 8:14 PM

$ORGO ...This piece of shit Mobags needs some serious IQ boosters, needs to take his meds, and needs to see a shrink...what a loser...

0 · Reply

Monticello4 Apr. 8 at 7:48 PM

$ORGO .

0 · Reply

karpeater Apr. 8 at 1:55 PM

$ORGO

0 · Reply

Mattew2627 Apr. 8 at 11:53 AM

$ORGO today 3.50$

0 · Reply

Xxxxcccemre Apr. 7 at 9:52 PM

$ORGO I want someone to explain to me what happened today . Incredible news stock goes up 30 percent and then gets dragged down to back to 0 percent I have seen this a lot since the war with small caps . Big gain after positive news and then rug pull Disgusting manipulation

0 · Reply

Muktar65 Apr. 7 at 9:19 PM

$ORGO BTIG analyst Ryan Zimmerman reiterates Organogenesis Holdings (NASDAQ:ORGO) with a Buy and maintains $8 price target

0 · Reply

_loutrades_ Apr. 7 at 7:50 PM

$ORGO whats wrong with this pos

0 · Reply

Monticello4 Apr. 7 at 7:48 PM

$ORGO 🤣

0 · Reply

Market Cap	299.73M
Revenue (ttm)	564.17M
Net Income (ttm)	37.03M
EPS (ttm)	N/A
PE Ratio	8.93
Forward PE	N/A
Profit Margin	6.56%
Debt to Equity Ratio	0.00

Volume	947,900
Avg Vol	1,309,128
Day's Range	N/A - N/A
Shares Out	128.64M
Stochastic %K	6%
Beta	1.48
Analysts	Strong Sell
Price Target	$8.00